Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Negro

Showing results (191-200 of 231) with videos related to

Pageof 24
Sort By:
JPEN. Journal of Parenteral and Enteral Nutrition|November 1, 1988
Sepsis and exogenous lipid modulationF B Cerra, P A Alden, F Negro, et al.
Lancet (London, England)|August 29, 1987
Liver transplantation in hepatitis delta virus diseaseM Rizzetto, S Macagno, E Chiaberge, et al.
Gastroenterology|August 1, 1994
Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2aF Negro, M Baldi, A Mondardini, et al.
Hepatology (Baltimore, Md.)|November 1, 1994
Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virusG Tappero, G Natoli, G Anfossi, et al.
Minerva Medica|November 30, 1986
[Cefotiam, a new cephalosporin. Microbiological research, preliminary evaluation of its effect on phagocytosis and clinical multicenter research]F Di Nola, R Arione, A Fabiano, et al.
Progress in Clinical and Biological Research|January 1, 1993
Towards a vaccine for the prevention of hepatitis delta virus superinfection in HBV carriersA Ponzetto, M Eckart, N D'Urso, et al.
Italian Journal of Gastroenterology and Hepatology|April 1, 1997
Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferonG Tappero, M Farina, F Negro, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2005
Impact of liver steatosis on virological response in [corrected] Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarinP Fabris, A Floreani, A Carlotto, et al.
The American Journal of Surgical Pathology|September 9, 1999
Primary hepatic diffuse large B-cell lymphoma in a patient with chronic hepatitis CL Rubbia-Brandt, M A Bründler, K Kerl, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2006
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activityS Zeuzem, A Alberti, W Rosenberg, et al.
Pageof 24

Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
JPEN. Journal of Parenteral and Enteral Nutrition|November 1, 1988
Sepsis and exogenous lipid modulationF B Cerra, P A Alden, F Negro, et al.
Lancet (London, England)|August 29, 1987
Liver transplantation in hepatitis delta virus diseaseM Rizzetto, S Macagno, E Chiaberge, et al.
Gastroenterology|August 1, 1994
Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2aF Negro, M Baldi, A Mondardini, et al.
Hepatology (Baltimore, Md.)|November 1, 1994
Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virusG Tappero, G Natoli, G Anfossi, et al.
Minerva Medica|November 30, 1986
[Cefotiam, a new cephalosporin. Microbiological research, preliminary evaluation of its effect on phagocytosis and clinical multicenter research]F Di Nola, R Arione, A Fabiano, et al.
Progress in Clinical and Biological Research|January 1, 1993
Towards a vaccine for the prevention of hepatitis delta virus superinfection in HBV carriersA Ponzetto, M Eckart, N D'Urso, et al.
Italian Journal of Gastroenterology and Hepatology|April 1, 1997
Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferonG Tappero, M Farina, F Negro, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2005
Impact of liver steatosis on virological response in [corrected] Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarinP Fabris, A Floreani, A Carlotto, et al.
The American Journal of Surgical Pathology|September 9, 1999
Primary hepatic diffuse large B-cell lymphoma in a patient with chronic hepatitis CL Rubbia-Brandt, M A Bründler, K Kerl, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2006
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activityS Zeuzem, A Alberti, W Rosenberg, et al.
Pageof 24